Table of Content

1 Herpes Labialis Drugs Market Overview
1.1 Herpes Labialis Drugs Product Scope
1.2 Herpes Labialis Drugs Segment by Type
1.2.1 Global Herpes Labialis Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Valacyclovir
1.2.3 Aciclovir
1.2.4 Famciclovir
1.2.5 Docosanol
1.2.6 Other
1.3 Herpes Labialis Drugs Segment by Application
1.3.1 Global Herpes Labialis Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Herpes Labialis Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Herpes Labialis Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Herpes Labialis Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Herpes Labialis Drugs Price Trends (2016-2027)

2 Herpes Labialis Drugs Estimates and Forecasts by Region
2.1 Global Herpes Labialis Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Herpes Labialis Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Herpes Labialis Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Herpes Labialis Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Herpes Labialis Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Herpes Labialis Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Herpes Labialis Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Herpes Labialis Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Herpes Labialis Drugs Estimates and Projections (2016-2027)
2.4.3 China Herpes Labialis Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Herpes Labialis Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Herpes Labialis Drugs Estimates and Projections (2016-2027)
2.4.6 India Herpes Labialis Drugs Estimates and Projections (2016-2027)

3 Global Herpes Labialis Drugs Competition Landscape by Players
3.1 Global Top Herpes Labialis Drugs Players by Sales (2016-2021)
3.2 Global Top Herpes Labialis Drugs Players by Revenue (2016-2021)
3.3 Global Herpes Labialis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Herpes Labialis Drugs as of 2020)
3.4 Global Herpes Labialis Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Herpes Labialis Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Herpes Labialis Drugs Market Size by Type
4.1 Global Herpes Labialis Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Herpes Labialis Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Herpes Labialis Drugs Price by Type (2016-2021)
4.2 Global Herpes Labialis Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Herpes Labialis Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Herpes Labialis Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Herpes Labialis Drugs Price Forecast by Type (2022-2027)

5 Global Herpes Labialis Drugs Market Size by Application
5.1 Global Herpes Labialis Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Herpes Labialis Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Herpes Labialis Drugs Price by Application (2016-2021)
5.2 Global Herpes Labialis Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Herpes Labialis Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Herpes Labialis Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Herpes Labialis Drugs Price Forecast by Application (2022-2027)

6 North America Herpes Labialis Drugs Market Facts & Figures
6.1 North America Herpes Labialis Drugs Sales by Company
6.1.1 North America Herpes Labialis Drugs Sales by Company (2016-2021)
6.1.2 North America Herpes Labialis Drugs Revenue by Company (2016-2021)
6.2 North America Herpes Labialis Drugs Sales Breakdown by Type
6.2.1 North America Herpes Labialis Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Herpes Labialis Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Herpes Labialis Drugs Sales Breakdown by Application
6.3.1 North America Herpes Labialis Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Herpes Labialis Drugs Sales Breakdown by Application (2022-2027)

7 Europe Herpes Labialis Drugs Market Facts & Figures
7.1 Europe Herpes Labialis Drugs Sales by Company
7.1.1 Europe Herpes Labialis Drugs Sales by Company (2016-2021)
7.1.2 Europe Herpes Labialis Drugs Revenue by Company (2016-2021)
7.2 Europe Herpes Labialis Drugs Sales Breakdown by Type
7.2.1 Europe Herpes Labialis Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Herpes Labialis Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Herpes Labialis Drugs Sales Breakdown by Application
7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)

8 China Herpes Labialis Drugs Market Facts & Figures
8.1 China Herpes Labialis Drugs Sales by Company
8.1.1 China Herpes Labialis Drugs Sales by Company (2016-2021)
8.1.2 China Herpes Labialis Drugs Revenue by Company (2016-2021)
8.2 China Herpes Labialis Drugs Sales Breakdown by Type
8.2.1 China Herpes Labialis Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Herpes Labialis Drugs Sales Breakdown by Type (2022-2027)
8.3 China Herpes Labialis Drugs Sales Breakdown by Application
8.3.1 China 156 Sales Breakdown by Application (2016-2021)
8.3.2 China 156 Sales Breakdown by Application (2022-2027)

9 Japan Herpes Labialis Drugs Market Facts & Figures
9.1 Japan Herpes Labialis Drugs Sales by Company
9.1.1 Japan Herpes Labialis Drugs Sales by Company (2016-2021)
9.1.2 Japan Herpes Labialis Drugs Revenue by Company (2016-2021)
9.2 Japan Herpes Labialis Drugs Sales Breakdown by Type
9.2.1 Japan Herpes Labialis Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Herpes Labialis Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Herpes Labialis Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Herpes Labialis Drugs Market Facts & Figures
10.1 Southeast Asia Herpes Labialis Drugs Sales by Company
10.1.1 Southeast Asia Herpes Labialis Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Herpes Labialis Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Herpes Labialis Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Herpes Labialis Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Herpes Labialis Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Herpes Labialis Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Herpes Labialis Drugs Market Facts & Figures
11.1 India Herpes Labialis Drugs Sales by Company
11.1.1 India Herpes Labialis Drugs Sales by Company (2016-2021)
11.1.2 India Herpes Labialis Drugs Revenue by Company (2016-2021)
11.2 India Herpes Labialis Drugs Sales Breakdown by Type
11.2.1 India Herpes Labialis Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Herpes Labialis Drugs Sales Breakdown by Type (2022-2027)
11.3 India Herpes Labialis Drugs Sales Breakdown by Application
11.3.1 India Herpes Labialis Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Herpes Labialis Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Herpes Labialis Drugs Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Herpes Labialis Drugs Products Offered
12.1.5 GSK Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Herpes Labialis Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Business Overview
12.3.3 Teva Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Teva Herpes Labialis Drugs Products Offered
12.3.5 Teva Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Business Overview
12.4.3 Mylan Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Herpes Labialis Drugs Products Offered
12.4.5 Mylan Recent Development
12.5 Cadila
12.5.1 Cadila Corporation Information
12.5.2 Cadila Business Overview
12.5.3 Cadila Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cadila Herpes Labialis Drugs Products Offered
12.5.5 Cadila Recent Development
12.6 Apotex
12.6.1 Apotex Corporation Information
12.6.2 Apotex Business Overview
12.6.3 Apotex Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Apotex Herpes Labialis Drugs Products Offered
12.6.5 Apotex Recent Development
12.7 Daewoong Pharmaceutical
12.7.1 Daewoong Pharmaceutical Corporation Information
12.7.2 Daewoong Pharmaceutical Business Overview
12.7.3 Daewoong Pharmaceutical Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Daewoong Pharmaceutical Herpes Labialis Drugs Products Offered
12.7.5 Daewoong Pharmaceutical Recent Development
12.8 Livzon
12.8.1 Livzon Corporation Information
12.8.2 Livzon Business Overview
12.8.3 Livzon Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Livzon Herpes Labialis Drugs Products Offered
12.8.5 Livzon Recent Development
12.9 Med Shine
12.9.1 Med Shine Corporation Information
12.9.2 Med Shine Business Overview
12.9.3 Med Shine Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Med Shine Herpes Labialis Drugs Products Offered
12.9.5 Med Shine Recent Development
12.10 Bayer
12.10.1 Bayer Corporation Information
12.10.2 Bayer Business Overview
12.10.3 Bayer Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Bayer Herpes Labialis Drugs Products Offered
12.10.5 Bayer Recent Development
12.11 Blistex
12.11.1 Blistex Corporation Information
12.11.2 Blistex Business Overview
12.11.3 Blistex Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Blistex Herpes Labialis Drugs Products Offered
12.11.5 Blistex Recent Development
12.12 Hikma
12.12.1 Hikma Corporation Information
12.12.2 Hikma Business Overview
12.12.3 Hikma Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Hikma Herpes Labialis Drugs Products Offered
12.12.5 Hikma Recent Development
12.13 Carmex
12.13.1 Carmex Corporation Information
12.13.2 Carmex Business Overview
12.13.3 Carmex Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Carmex Herpes Labialis Drugs Products Offered
12.13.5 Carmex Recent Development
12.14 Cipher
12.14.1 Cipher Corporation Information
12.14.2 Cipher Business Overview
12.14.3 Cipher Herpes Labialis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Cipher Herpes Labialis Drugs Products Offered
12.14.5 Cipher Recent Development

13 Herpes Labialis Drugs Manufacturing Cost Analysis
13.1 Herpes Labialis Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Herpes Labialis Drugs
13.4 Herpes Labialis Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Herpes Labialis Drugs Distributors List
14.3 Herpes Labialis Drugs Customers

15 Market Dynamics
15.1 Herpes Labialis Drugs Market Trends
15.2 Herpes Labialis Drugs Drivers
15.3 Herpes Labialis Drugs Market Challenges
15.4 Herpes Labialis Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Herpes Labialis Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Herpes Labialis Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Herpes Labialis Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Herpes Labialis Drugs Sales (K Pcs) by Region (2016-2021)
Table 5. Global Herpes Labialis Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Herpes Labialis Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Herpes Labialis Drugs Revenue Share by Region (2016-2021)
Table 8. Global Herpes Labialis Drugs Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Herpes Labialis Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Herpes Labialis Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Herpes Labialis Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Herpes Labialis Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Herpes Labialis Drugs Sales Share by Company (2016-2021)
Table 14. Global Herpes Labialis Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Herpes Labialis Drugs Revenue Share by Company (2016-2021)
Table 16. Global Herpes Labialis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Labialis Drugs as of 2020)
Table 17. Global Herpes Labialis Drugs Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Herpes Labialis Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Herpes Labialis Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Herpes Labialis Drugs Sales (K Pcs) by Type (2016-2021)
Table 22. Global Herpes Labialis Drugs Sales Share by Type (2016-2021)
Table 23. Global Herpes Labialis Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Herpes Labialis Drugs Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Herpes Labialis Drugs Sales Share by Type (2022-2027)
Table 26. Global Herpes Labialis Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Herpes Labialis Drugs Revenue Share by Type (2022-2027)
Table 28. Global Herpes Labialis Drugs Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Herpes Labialis Drugs Sales (K Pcs) by Application (2016-2021)
Table 30. Global Herpes Labialis Drugs Sales Share by Application (2016-2021)
Table 31. Global Herpes Labialis Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Herpes Labialis Drugs Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Herpes Labialis Drugs Sales (K Pcs) by Application (2022-2027)
Table 34. Global Herpes Labialis Drugs Sales Share by Application (2022-2027)
Table 35. Global Herpes Labialis Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Herpes Labialis Drugs Revenue Share by Application (2022-2027)
Table 37. Global Herpes Labialis Drugs Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Herpes Labialis Drugs Sales (K Pcs) by Company (2016-2021)
Table 39. North America Herpes Labialis Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Herpes Labialis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Herpes Labialis Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Herpes Labialis Drugs Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Herpes Labialis Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Herpes Labialis Drugs Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Herpes Labialis Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Herpes Labialis Drugs Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Herpes Labialis Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Herpes Labialis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Herpes Labialis Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Herpes Labialis Drugs Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Herpes Labialis Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Herpes Labialis Drugs Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Herpes Labialis Drugs Sales Market Share by Application (2022-2027)
Table 62. China Herpes Labialis Drugs Sales (K Pcs) by Company (2016-2021)
Table 63. China Herpes Labialis Drugs Sales Market Share by Company (2016-2021)
Table 64. China Herpes Labialis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Herpes Labialis Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 67. China Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 68. China Herpes Labialis Drugs Sales by Type (2022-2027) & (K Pcs)
Table 69. China Herpes Labialis Drugs Sales Market Share by Type (2022-2027)
Table 70. China Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 71. China Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 72. China Herpes Labialis Drugs Sales by Application (2022-2027) & (K Pcs)
Table 73. China Herpes Labialis Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Herpes Labialis Drugs Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Herpes Labialis Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Herpes Labialis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Herpes Labialis Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Herpes Labialis Drugs Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Herpes Labialis Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Herpes Labialis Drugs Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Herpes Labialis Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Herpes Labialis Drugs Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Herpes Labialis Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Herpes Labialis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Herpes Labialis Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Herpes Labialis Drugs Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Herpes Labialis Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Herpes Labialis Drugs Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Herpes Labialis Drugs Sales Market Share by Application (2022-2027)
Table 98. India Herpes Labialis Drugs Sales (K Pcs) by Company (2016-2021)
Table 99. India Herpes Labialis Drugs Sales Market Share by Company (2016-2021)
Table 100. India Herpes Labialis Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Herpes Labialis Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 103. India Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 104. India Herpes Labialis Drugs Sales by Type (2022-2027) & (K Pcs)
Table 105. India Herpes Labialis Drugs Sales Market Share by Type (2022-2027)
Table 106. India Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 107. India Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 108. India Herpes Labialis Drugs Sales by Application (2022-2027) & (K Pcs)
Table 109. India Herpes Labialis Drugs Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. GSK Herpes Labialis Drugs Product
Table 114. GSK Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Novartis Herpes Labialis Drugs Product
Table 119. Novartis Recent Development
Table 120. Teva Corporation Information
Table 121. Teva Description and Business Overview
Table 122. Teva Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Teva Herpes Labialis Drugs Product
Table 124. Teva Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Mylan Herpes Labialis Drugs Product
Table 129. Mylan Recent Development
Table 130. Cadila Corporation Information
Table 131. Cadila Description and Business Overview
Table 132. Cadila Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Cadila Herpes Labialis Drugs Product
Table 134. Cadila Recent Development
Table 135. Apotex Corporation Information
Table 136. Apotex Description and Business Overview
Table 137. Apotex Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Apotex Herpes Labialis Drugs Product
Table 139. Apotex Recent Development
Table 140. Daewoong Pharmaceutical Corporation Information
Table 141. Daewoong Pharmaceutical Description and Business Overview
Table 142. Daewoong Pharmaceutical Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Daewoong Pharmaceutical Herpes Labialis Drugs Product
Table 144. Daewoong Pharmaceutical Recent Development
Table 145. Livzon Corporation Information
Table 146. Livzon Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Livzon Description and Business Overview
Table 148. Livzon Herpes Labialis Drugs Product
Table 149. Livzon Recent Development
Table 150. Med Shine Corporation Information
Table 151. Med Shine Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Med Shine Description and Business Overview
Table 153. Med Shine Herpes Labialis Drugs Product
Table 154. Med Shine Recent Development
Table 155. Bayer Corporation Information
Table 156. Bayer Description and Business Overview
Table 157. Bayer Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Bayer Herpes Labialis Drugs Product
Table 159. Bayer Recent Development
Table 160. Blistex Corporation Information
Table 161. Blistex Description and Business Overview
Table 162. Blistex Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Blistex Herpes Labialis Drugs Product
Table 164. Blistex Recent Development
Table 165. Hikma Corporation Information
Table 166. Hikma Description and Business Overview
Table 167. Hikma Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Hikma Herpes Labialis Drugs Product
Table 169. Hikma Recent Development
Table 170. Carmex Corporation Information
Table 171. Carmex Description and Business Overview
Table 172. Carmex Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Carmex Herpes Labialis Drugs Product
Table 174. Carmex Recent Development
Table 175. Cipher Corporation Information
Table 176. Cipher Description and Business Overview
Table 177. Cipher Herpes Labialis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Cipher Herpes Labialis Drugs Product
Table 179. Cipher Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Herpes Labialis Drugs Distributors List
Table 183. Herpes Labialis Drugs Customers List
Table 184. Herpes Labialis Drugs Market Trends
Table 185. Herpes Labialis Drugs Market Drivers
Table 186. Herpes Labialis Drugs Market Challenges
Table 187. Herpes Labialis Drugs Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Herpes Labialis Drugs Product Picture
Figure 2. Global Herpes Labialis Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Valacyclovir Product Picture
Figure 4. Aciclovir Product Picture
Figure 5. Famciclovir Product Picture
Figure 6. Docosanol Product Picture
Figure 7. Other Product Picture
Figure 8. Global Herpes Labialis Drugs Sales Market Share by Application in 2021 & 2027
Figure 9. External Use Examples
Figure 10. Oral Examples
Figure 11. Injection Examples
Figure 12. Global Herpes Labialis Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Herpes Labialis Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Herpes Labialis Drugs Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Herpes Labialis Drugs Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Herpes Labialis Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Herpes Labialis Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Herpes Labialis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Herpes Labialis Drugs Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Herpes Labialis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Herpes Labialis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Herpes Labialis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Herpes Labialis Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Herpes Labialis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Herpes Labialis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Herpes Labialis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Herpes Labialis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Herpes Labialis Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Herpes Labialis Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Herpes Labialis Drugs Players Market Share by Revenue in Herpes Labialis Drugs: 2016 & 2020
Figure 31. Herpes Labialis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Herpes Labialis Drugs Revenue Share by Type (2016-2021)
Figure 33. Global Herpes Labialis Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Herpes Labialis Drugs Revenue Share by Application (2016-2021)
Figure 35. Global Herpes Labialis Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 37. North America Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 38. Europe Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 39. Europe Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 40. China Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 41. China Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 42. Japan Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 43. Japan Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 44. Southeast Asia Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 45. Southeast Asia Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 46. India Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 47. India Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Herpes Labialis Drugs
Figure 50. Manufacturing Process Analysis of Herpes Labialis Drugs
Figure 51. Herpes Labialis Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed